DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Unum Therapeutics Says Was Verbally Notified By FDA That It Had Placed PArtial Clinical Hold On Phase 1 Trial Of ACTR707 In Combination With RITUXIMAB

Benzinga · 03/09/2020 20:36